Lymphangioma circumscriptum, one of the common forms of lymphangioma, can be either congenital or acquired. Various acquired conditions can lead to its causation and one of the causes might be untreated hidradenitis suppurativa. So, this report highlights the need of early interventions for hidradenitis suppurativa as lymphangioma circumscriptum can be one of its consequences later in life. It can occur in various sites, often around neck, axilla, and groin. Post-surgery and radiotherapy, tuberculosis, Crohn's disease are well known cause to develop acquired vulval lymphangioma. Here, we present a case of a 20 years female with acquired vulval lymphangioma secondary to hidradenitis suppurativa which is one of the rare cause for vulval lymphangioma.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686588 | PMC |
http://dx.doi.org/10.1002/ccr3.70034 | DOI Listing |
Arch Dermatol Res
January 2025
Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
J Eur Acad Dermatol Venereol
January 2025
Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
J Cutan Pathol
January 2025
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
The term autoinflammatory keratinization diseases (AIKDs) was recently proposed as a unifying concept for diseases characterized by inflammation in the epidermis and upper dermis which leads to hyperkeratosis, caused by genetic perturbations of the innate immune system. We present a case of a patient with hidradenitis suppurativa and porokeratosis, two AIKDs, followed by a review of these conditions as well as other AIKDs. This case was distinguished by hypertrophic porokeratoses involving cystic hair follicles, showing histopathologic features of both conditions within single biopsy specimens.
View Article and Find Full Text PDFActas Dermosifiliogr
December 2024
Servicio de Dermatología. Hospital Universitario de Guadalajara, Guadalajara, España.
Autoimmun Rev
December 2024
Rheumatology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom.
Introduction: The use of Janus kinase inhibitors (JAKis) in immune-mediated inflammatory diseases (IMIDs) beyond licence is expanding rapidly. The aim of this scoping review was to identify and present the available evidence on the efficacy of JAKis in all conditions without marketing authorisation.
Methods: Through a systematic literature search we identified studies including 5 or more patients that assessed the use of any JAKi for any efficacy outcome.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!